A human DPP4-knockin mouse's susceptibility to infection by authentic and pseudotyped MERS-CoV

C Fan, X Wu, Q Liu, Q Li, S Liu, J Lu, Y Yang, Y Cao… - Viruses, 2018 - mdpi.com
Infection by the Middle East respiratory syndrome coronavirus (MERS-CoV) causes
respiratory illness and has a high mortality rate (~ 35%). The requirement for the virus to be …

Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus …

AS Agrawal, T Ying, X Tao, T Garron, A Algaissi… - Scientific reports, 2016 - nature.com
Abstract Middle East Respiratory Syndrome coronavirus (MERS-CoV) has repeatedly
caused outbreaks in the Arabian Peninsula. To date, no approved medical countermeasures …

Contributions of farm animals to immunology

E Guzman, M Montoya - Frontiers in veterinary science, 2018 - frontiersin.org
By their very nature, great advances in immunology are usually underpinned by experiments
carried out in animal models and inbred lines of mice. Also, their corresponding knock-out or …

Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines

T Gilliland, Y Liu, R Li, M Dunn, E Cottle, Y Terada… - BioRxiv, 2021 - biorxiv.org
Pandemic SARS CoV-2 has been undergoing rapid evolution during spread throughout the
world resulting in the emergence of many Spike protein variants, some of which appear to …

A fully human monoclonal antibody possesses antibody‐dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a …

R Gao, Z Wang, T Uprety… - Journal of Medical …, 2023 - Wiley Online Library
The DiversitabTM system produces target specific high titer fully human polyclonal IgG
immunoglobulins from transchromosomic (Tc) bovines shown to be safe and effective …

Potential therapeutic approach of intravenous immunoglobulin against COVID-19

Z Kolahchi, H Sohrabi, S Ekrami Nasab… - Allergy, Asthma & …, 2021 - Springer
Since the outbreak of the novel coronavirus disease (COVID-19), the therapeutic and
management options to reduce the burden of the COVID-19 disease are under investigation …

[HTML][HTML] Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants

T Gilliland, M Dunn, Y Liu, MDH Alcorn, Y Terada… - Iscience, 2023 - cell.com
Pandemic SARS-CoV-2 has undergone rapid evolution resulting in the emergence of many
variants with mutations in the spike protein, some of which appear to evade antibody …

Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model

Y Zhao, C Wang, B Qiu, C Li, H Wang, H Jin, W Gai… - Antiviral research, 2017 - Elsevier
Abstract Middle East Respiratory Syndrome (MERS) is a highly lethal pulmonary infection
caused by a coronavirus (CoV), MERS-CoV. With the continuing spread of MERS-CoV …

Development of Middle East respiratory syndrome coronavirus vaccines–advances and challenges

H Cho, JL Excler, JH Kim, IK Yoon - Human Vaccines & …, 2018 - Taylor & Francis
ABSTRACT Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an emerging
pathogen with the potential to pose a threat to global public health. Sporadic cases and …

[引用][C] 新型冠状病毒(2019-nCoV) 治疗药物体内外研究及药物研发进展

宋杲, 成梦群, 魏贤文 - 病毒学报, 2020